Biodel AG

Proprietary Solutions to Restore Soil Health, Save Water & Sequester CO2
Overview
Raised: $145,181
Total Commitments ($USD)
Wefunder
08/25/2022
01/20/2023
$50,000
$1,500,000
$250
Convertible Note
Seed
RegCF
$25,000,000
20%
Rolling Commitments ($USD)
01/31/2023
290%
10%
$981
134
Maricopa, Arizona
Farming & Agriculture
AgriTech
B2B/B2C
Medium
Low
Summary Profit and Loss Statement
Most Recent Year | Prior Year | |
---|---|---|
Revenue |
$372,565 |
$220,004 |
COGS |
$162,633 |
$100,885 |
Tax |
$4,469 |
$50 |
| ||
| ||
Net Income |
$-250,988 |
$-348,058 |
Summary Balance Sheet
Most Recent Year | Prior Year | |
---|---|---|
Cash |
$67,592 |
$4,998 |
Accounts Receivable |
$49,581 |
$4,600 |
Total Assets |
$1,797,782 |
$1,424,850 |
Short-Term Debt |
$496,130 |
$487,188 |
Long-Term Debt |
$197,655 |
$5,000 |
Total Liabilities |
$693,785 |
$492,188 |
Upgrade to gain access
-
$12.42 /month
billed annually - Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings (excluding risk)
- Advanced company search ( with ratings)
- Markets page filters and historical industry data
- Get Edge Annual
Edge
-
$41.58 /month
billed annually - Full site access including KingsCrowd's qualitative analyst reports.
- Plan Includes:
- Everything in Edge, plus
- Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
- Search and filter based on Analyst Reports
- In-depth risk ratings for every raise
- Get Edge Pro Annual
Edge Pro
Wall Street has Morningstar, S&P, and Bloomberg
The equity crowdfunding market has KingsCrowd.
Moonshot companies are tricky to evaluate. By definition, moonshots are bold, audacious, innovative attempts to solve massive problems. And if the solution is successful, it can be immensely profitable for investors and beneficial for society.
Moonshots are also incredibly risky. Such innovative solutions are difficult to build. And often, it takes a long time before society adopts a moonshot solution. It’s hard to overcome decades of doing something the same way.
That’s why timing is incredibly important when investing in moonshots. We know that many early stage moonshot companies are at least a decade away from succeeding. Investing in them often means waiting a long time before seeing any returns.
But every now and then, a moonshot company arrives on the scene at precisely the right moment — when a problem is so big and pressing that the world needs to adopt a working solution right away. And if a moonshot company has a working solution — and clear pathway to growth and monetization — that dramatically reduces the company’s risk profile and makes it extremely attractive to startup investors.
We believe Biodel AG is one of these special moonshot companies.